Category: News


2018 TCT: More Than 30 Sessions Showcasing Impella® Technology

Subscribe here for updates from ProtectedPCI.com during TCT 2018.   Abiomed Booth Hours – Booth #829   Visit Abiomed’s booth for demonstrations, clinical data review and opportunities  to engage in hands-on simulations of the Impella platform. Saturday September 22, 2018:                   8:00 AM – 5:00 PM Sunday, September 23, 2018:  … Continue reading “2018 TCT: More Than 30 Sessions Showcasing Impella® Technology”

Detroit Cardiogenic Shock Initiative: Initial Results

Data presented by Dr. William O’Neill of Henry Ford Hospital System at the 66th Annual Scientific Session of the American College of Cardiology also included new data from the Detroit Cardiogenic Shock Initiative (DCSI), an unprecedented collaboration between five heart hospitals in Detroit, with the goal of determining whether outcomes in cardiogenic shock can be … Continue reading “Detroit Cardiogenic Shock Initiative: Initial Results”

Impella® Quality Assurance Program: Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery

  Data from Abiomed’s Impella® Quality (IQ) Assurance Program, which includes the IQ Database and cVAD Registry, was presented today as late-breaking Featured Clinical Research by Dr. William O’Neill of Henry Ford Hospital System at the American College of Cardiology (ACC) 66th Annual Scientific Session in Washington, D.C. These data were derived from the IQ Database … Continue reading “Impella® Quality Assurance Program: Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery”

A Compelling Case for Revascularization: Specialist Opinion by Dr. Marty Leon

Dr. Marty Leon outlines the important role of hemodynamic support for complete revascularization in CHIP patients. Subscribe, or join the conversation by following us on Twitter: @ProtectedPCI ICP-075-16 To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/

Detroit CSI: Collaboration to Improve Outcomes in Cardiogenic Shock

Announced Wednesday, the Detroit Cardiogenic Shock Initiative (CSI) is an innovative collaboration between five hospital systems in metro Detroit with the goal of determining whether outcomes in cardiogenic shock can be improved by using Impella® as early as possible for patients in the shock spiral. View the Full Story Here Led by Dr. Bill O’Neill … Continue reading “Detroit CSI: Collaboration to Improve Outcomes in Cardiogenic Shock”

Hemodynamic Support Provides Benefits in Cardiogenic Shock

Dramatic improvements in interventional techniques have produced advances in almost every aspect of cardiac care over the past decade. But one area has been a major challenge: In cardiogenic shock, mortality has remained high as incidence has gradually climbed. Several factors appear to influence outcomes in patients with AMI complicated by cardiogenic shock who are … Continue reading “Hemodynamic Support Provides Benefits in Cardiogenic Shock”

cVAD Registry Pursues Best Practices for Cardiogenic Shock

Although percutaneous circulatory support has seen exponential growth over the last decade, there is a need for real-world data on complex patients to develop best practices, aid research and improve outcomes. But large randomized clinical trials involving cardiogenic shock patients are difficult to conduct, so the global cVAD registry was created, said Brij Maini, MD, … Continue reading “cVAD Registry Pursues Best Practices for Cardiogenic Shock”